Literature DB >> 8609039

Human T-lymphotropic virus type II in Japan.

H Yoshizaki1, K Kitamura, A Oki, S Yahara, R Yamanaka, Y Fukushima, K Komuro, S Yamazaki, M Honda.   

Abstract

Serum specimens were assayed for human T-lymphotropic virus type II(HTLV-II) infection in 1,500 individuals known to be seropositive for HTLV-I and 30,000 blood donors in Japan. All HTLV-I-positive individuals were negative for HTLV-II. However, one of the blood donors was clearly seropositive for HTLV-II. Further, the donor was shown to be positive for HTLV-IIb. Here we report at least one case with HTLV-II in Japan and discuss the origin of the infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8609039      PMCID: PMC5920975          DOI: 10.1111/j.1349-7006.1996.tb00191.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  12 in total

1.  Development of a supersensitive polymerase chain reaction method for human T lymphotropic virus type II (HTLV-II) and detection of HTLV-II proviral DNA from blood donors in Japan.

Authors:  T Hamakado; T Matsumoto; Y Koyanagi; K Hayashi; K Fukada; T Kouchiyama; T Yoshida; N Yamamoto
Journal:  Virus Genes       Date:  1992-04       Impact factor: 2.332

2.  HTLV-II in patients with HTLV-I-associated myelopathy.

Authors:  J Kira; Y Koyanagi; T Hamakado; Y Itoyama; N Yamamoto; I Goto
Journal:  Lancet       Date:  1991-07-06       Impact factor: 79.321

3.  Lack of anti-HTLV-II seropositivity in HTLV-I-associated myelopathy and adult T-cell leukaemia.

Authors:  T Kiyokawa; K Yamaguchi; Y Nishimura; K Yoshiki; K Takatsuki
Journal:  Lancet       Date:  1991-08-17       Impact factor: 79.321

Review 4.  Seminars in medicine of the Beth Israel Hospital, Boston. Pathogenesis of diseases induced by human lymphotropic virus type I infection.

Authors:  P Höllsberg; D A Hafler
Journal:  N Engl J Med       Date:  1993-04-22       Impact factor: 91.245

5.  Lack of evidence for HTLV-II infection in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in an endemic area.

Authors:  S Ijichi; W W Hall; R Kubota; M Osame
Journal:  AIDS Res Hum Retroviruses       Date:  1993-05       Impact factor: 2.205

6.  Human T-lymphotropic virus type II in Vietnam.

Authors:  Y Fukushima; T Nakasone; S Nakata; S Pham; D D Dao; K Komuro; M Honda
Journal:  Lancet       Date:  1994-08-13       Impact factor: 79.321

7.  HTLV-II subtype b among injecting drug users in Spain.

Authors:  A Vallejo; A García-Sáiz
Journal:  Vox Sang       Date:  1994       Impact factor: 2.144

8.  Japanese patients with chronic fatigue syndrome are negative for known retrovirus infections.

Authors:  M Honda; K Kitamura; T Nakasone; Y Fukushima; S Matsuda; K Nishioka; J Matsuda; N Hashimoto; S Yamazaki
Journal:  Microbiol Immunol       Date:  1993       Impact factor: 1.955

9.  Extraordinary high rate of HTLV type II seropositivity in intravenous drug abusers in south Vietnam.

Authors:  Y Fukushima; H Takahashi; W W Hall; T Nakasone; S Nakata; P Song; D Dinh Duc; B Hien; X Q Nguyen; T Ngoc Trinh
Journal:  AIDS Res Hum Retroviruses       Date:  1995-05       Impact factor: 2.205

10.  Detection of HTLV-II-seropositive blood donors in South Vietnam but not in North Vietnam.

Authors:  S Yamamoto; S Nakata; T Nakasone; T Chosa; P Song; D D Duc; B Hien; N X Quang; T N Trinh; T Ono
Journal:  Jpn J Cancer Res       Date:  1994-09
View more
  1 in total

1.  Nucleotide sequence variation of human T-lymphotropic virus type II in Vietnam.

Authors:  H Yoshizaki; T Nakasone; T Nakasatomi; S Kusagawa; H Sato; T H Nguyen; H A Mai; T L Hoang; Y Takebe; M Honda
Journal:  Jpn J Cancer Res       Date:  1997-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.